Rotterdam, 11 June 2025 – Sensius, a pioneer in precision thermotherapy for oncology, today announced the successful completion of a €15…
David has worked as a Regulatory, Clinical, and Scientific Affairs Consultant for medical device and pharmaceutical manufacturers since…
Since April 2025 2 new people have joined Sensius. We are proud to present our new colleagues who will contribute to the Sensius product…
Additional Heat Treatment for Head and Neck Cancer The Erasmus Medical Center (Erasmus MC) will conduct research on a new supplementary…
Aim is to turn 20% of its members into unicorns Sensius is proud to announce that it has been selected as a member of the EIC Scaling Club…
Sensius and AMG Medtech, their UK sales agent, hosted a hybrid meeting during ESTRO 2024 in Glasgow over the weekend. Clinicians from…
During the ASTRO Head and Neck conference in Phoenix AZ, Sensius hosted a meeting with 6 USA-based clinics. The intention of the meeting…
Sensius hits another milestone on the journey to market We worked hard to build up our quality system last year, which has resulted in in…
Sensius is pleased to announce the appointment of Peter van Paassen as Non-Executive Director, effective immediately. Before this…
A critical milestone for the evidence base of thermotherapy has been achieved with the start of the TANCA phase I trial in ErasmusMC. By…
On November 20, 2023, representatives from Z43 and project partners SENSIUS B.V., Technische Universiteit Eindhoven (TU/e) and Erasmus…
UK Thermotherapy Special Interest GroupOn the 20th October 2023 the first meeting of the Special Interest Group was held. Clinicians and…
